Alydar Partners’s MiMedx Group MDXG Stock Holding History

Alydar Partners’s Portfolio MDXG Stock Details MDXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-900,000	Closed	-$7.87M	–	120
2013 Q4	$7.87M	Buy	+900,000	New	+$5.51M	0.8%	39

Other funds holding MDXG

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

TCM

Tamarack Capital Management Carlsbad, California $840M AUM 19.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Alydar Partners's MDXG Position: Q1 2014 in Review

Alydar Partners sold out of MiMedx Group (MDXG) in Q1 2014, closing a stake of 900,000 shares — an estimated $7.87M sold.

Alydar Partners first reported a position in MDXG in Q4 2013 and held it in 1 quarter. The position peaked at $7.87M in Q4 2013. 108 funds tracked by Wall St. Rank hold MDXG as of Q1 2014.

Alydar Partners reported no remaining MiMedx Group position as of Q1 2014 after selling out during the quarter.
Alydar Partners sold 900,000 MiMedx Group shares in Q1 2014, an estimated $7.87M.
Alydar Partners first reported a position in MiMedx Group in Q4 2013 and held it in 1 quarter.
Alydar Partners's MiMedx Group position peaked at $7.87M in Q4 2013.
108 funds tracked by Wall St. Rank held MiMedx Group as of Q1 2014.

Based on Alydar Partners's 13F filing for Q1 2014, filed 15 May 2014.